Estradiol-mediated inhibition of Sp1 decreases miR-3194-5p expression to enhance CD44 expression during lung cancer progression.

MLA

Young, Ming-Jer, et al. “Estradiol-Mediated Inhibition of Sp1 Decreases MiR-3194-5p Expression to Enhance CD44 Expression during Lung Cancer Progression.” Journal of Biomedical Science, vol. 29, no. 1, Jan. 2022, p. 3. EBSCOhost, https://doi.org/10.1186/s12929-022-00787-1.

APA

Young, M.-J., Chen, Y.-C., Wang, S.-A., Chang, H.-P., Yang, W.-B., Lee, C.-C., Liu, C.-Y., Tseng, Y.-L., Wang, Y.-C., Sun, H. S., Chang, W.-C., & Hung, J.-J. (2022). Estradiol-mediated inhibition of Sp1 decreases miR-3194-5p expression to enhance CD44 expression during lung cancer progression. Journal of Biomedical Science, 29(1), 3. https://doi.org/10.1186/s12929-022-00787-1

Chicago

Young, Ming-Jer, Yung-Ching Chen, Shao-An Wang, Hui-Ping Chang, Wen-Bin Yang, Chia-Chi Lee, Chia-Yu Liu, et al. 2022. “Estradiol-Mediated Inhibition of Sp1 Decreases MiR-3194-5p Expression to Enhance CD44 Expression during Lung Cancer Progression.” Journal of Biomedical Science 29 (1): 3. doi:10.1186/s12929-022-00787-1.